New pill aims to tame severe eczema itch and rash
NCT ID NCT07193589
Summary
This study is testing whether a new oral drug called ZL-82 can help control moderate to severe atopic dermatitis (eczema) in adults. About 111 participants will take either ZL-82 or a placebo pill daily for 16 weeks to see if it reduces the severity of their skin rash and itching. Researchers will compare the two groups to check if the drug is effective and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
West China Hospital Sichuan University
RECRUITINGChengdu, Sichuan, 610200, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.